PISTELLI, MIRCO
 Distribuzione geografica
Continente #
NA - Nord America 1.480
EU - Europa 575
AS - Asia 400
SA - Sud America 81
AF - Africa 57
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 2.597
Nazione #
US - Stati Uniti d'America 1.463
SG - Singapore 154
IT - Italia 125
CN - Cina 114
SE - Svezia 76
BR - Brasile 70
IE - Irlanda 70
DE - Germania 63
UA - Ucraina 58
RU - Federazione Russa 55
CI - Costa d'Avorio 43
HK - Hong Kong 37
GB - Regno Unito 36
VN - Vietnam 31
FI - Finlandia 25
FR - Francia 21
TR - Turchia 21
DK - Danimarca 14
IN - India 14
PL - Polonia 11
CA - Canada 10
KR - Corea 10
JP - Giappone 8
MA - Marocco 7
MX - Messico 7
BD - Bangladesh 6
AR - Argentina 5
ES - Italia 5
ZA - Sudafrica 5
BE - Belgio 4
NL - Olanda 4
AT - Austria 3
AU - Australia 2
CO - Colombia 2
EC - Ecuador 2
EU - Europa 2
LB - Libano 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
IQ - Iraq 1
KE - Kenya 1
LT - Lituania 1
MD - Moldavia 1
PS - Palestinian Territory 1
RO - Romania 1
SR - Suriname 1
UY - Uruguay 1
Totale 2.597
Città #
Ashburn 196
Chandler 170
Dallas 119
Singapore 96
Jacksonville 89
Fairfield 80
Dublin 69
New York 64
Boardman 56
Des Moines 55
Abidjan 43
Houston 43
Woodbridge 40
Seattle 39
Wilmington 38
Hong Kong 37
Beijing 31
Los Angeles 28
Cambridge 27
Lawrence 22
Munich 22
Princeton 22
Ann Arbor 21
San Mateo 20
Rome 19
Centro 15
The Dalles 15
Chicago 13
Turku 13
San Diego 12
Ho Chi Minh City 11
São Paulo 11
Buffalo 10
Washington 10
London 9
Turin 9
Warsaw 9
Moscow 8
Porto 8
Hefei 7
Montreal 7
Stockholm 7
Cagliari 6
Phoenix 6
Tokyo 6
Ancona 5
Brooklyn 5
Cantu 5
Chennai 5
Chiaravalle 5
Falls Church 5
Guangzhou 5
Helsinki 5
Santa Clara 5
Boston 4
Brasília 4
Brussels 4
Hanoi 4
Johannesburg 4
Mexico City 4
Prescot 4
Pune 4
Rio de Janeiro 4
Ankara 3
Birmingham 3
Biên Hòa 3
Campinas 3
Columbus 3
Denver 3
Falconara Marittima 3
Frankfurt am Main 3
Kilburn 3
Manchester 3
Mumbai 3
Orem 3
Poplar 3
Salt Lake City 3
San Francisco 3
Wuhan 3
Yiwu 3
Atlanta 2
Calgary 2
Caserta 2
Chengdu 2
Cosenza 2
Hangzhou 2
Hải Dương 2
Ilford 2
Lancaster 2
Marche 2
Milan 2
Nuremberg 2
Osimo 2
Qingdao 2
Recanati 2
Redmond 2
Redwood City 2
Rho 2
Richmond 2
Santa Croce sull'Arno 2
Totale 1.810
Nome #
Prospective observational study of taste assay in patients with solid tumors treated with standard chemotherapy (POTATO) 148
Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients 145
Long‑responders to anti‑HER2 therapies: A case report and review of the literature 140
Role of DCE-MR imaging of the breast in predicting breast cancer subtypes: where are we going? 139
Role of DCE-MR in predicting breast cancer subtypes. 135
Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations. 132
Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients 132
Paclitaxel and Bevacizumab in First Line-Treatment Patients with HER-2 Negative Advanced Breast Cancer: Who could Benefit? 118
Irinotecan-Induced Transient Dysarthria: Case Series and Updated Literature Review 118
Everolimus and exemestane in long survival hormone receptor positive male breast cancer: case report 110
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 110
The impact of lifestyle interventions in high‐risk early breast cancer patients: A modeling approach from a single institution experience 109
Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients. 107
Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis 106
Expectations and psychological issues before genetic counseling: analysis of distress determinant factors 105
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 101
Comparison Between Alendronate and Denosumab in Preventing Bone Loss and Lowering Fracture Risk Related to Adjuvant Endocrine Therapy for Breast Cancer: Real-World Data From a Third-Level Center Experience 97
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 96
A Mixed-apprOach program To help women wIth breast cancer stay actiVE (MOTIVE program): A pilot-controlled study 95
Healthcare cost of HER2-positive and negative breast tumors in the United States (2012–2035) 92
Adjuvant Systemic Therapy in DCIS 83
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study 80
Espressione di p-mTOR e del recettore degli androgeni nei tumori mammari triplo negativi: significato clinico e potenziali prospettive terapeutiche 79
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study 70
Totale 2.647
Categoria #
all - tutte 12.876
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.876


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021197 0 0 0 0 0 26 22 28 32 39 33 17
2021/2022184 12 28 4 1 2 29 11 9 17 22 17 32
2022/2023455 31 58 30 49 27 99 0 15 97 2 24 23
2023/2024242 46 3 16 17 33 70 4 16 0 3 0 34
2024/2025415 65 45 11 9 24 12 35 10 74 22 55 53
2025/2026762 120 94 149 167 178 54 0 0 0 0 0 0
Totale 2.647